Phase I study of a 40kDa branched pegylated-interferon alpha-2a (PEGASYS (TM)) in patients with advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Motzer, R.; Berg, W.; Rakhit, A.; Ginsberg, M.; Rittweger, K.; Fettner, S.; Yu, R.; Hooftman, L. |
| Abstract Title: | Phase I study of a 40kDa branched pegylated-interferon alpha-2a (PEGASYS (TM)) in patients with advanced renal cell carcinoma (RCC) |
| Meeting Title: | 25th European Society of Medical Oncology (ESMO) Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 11 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2000 Oct 13-17 |
| Meeting Location: | Hamburg, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2000-01-01 |
| Start Page: | 74 |
| End Page: | 75 |
| Language: | English |
| ACCESSION: | WOS:000089503900330 |
| PROVIDER: | wos |
| PUBMED: | 11077566 |
| DOI: | 10.1093/annonc/11.suppl_4.73 |
| Notes: | Meeting Abstract: 329O -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
